身体衰弱与慢阻肺共存及其与残疾和死亡率的关联:新加坡纵向老龄化研究
该前瞻性队列研究纳入新加坡社区≥55岁居民,比较1,162例慢阻肺患者与3,465例非慢阻肺者的身体衰弱情况并随访3至11年。慢阻肺患者衰弱共存风险增高(OR 1.61,95%CI 1.15-2.26),衰弱与FEV1<80%或呼吸困难联合可显著预测残疾与死亡风险。
要点
- 慢阻肺患者衰弱共存风险显著高于非慢阻肺者。
- 衰弱与FEV1<80%或呼吸困难联合时残疾与死亡风险明显升高。
- 建议在慢阻肺多维评估中纳入身体衰弱。
核心结论
- 研究支持在慢阻肺多维评估中,于肺功能和呼吸困难之外纳入身体衰弱评估。
研究设计与样本
- 新加坡纵向老龄化研究中的前瞻性队列研究,纳入社区居住≥55岁成人。
- 基线包括1,162例慢阻肺患者和3,465例非慢阻肺者,评估身体衰弱、FEV1占预计值百分比和呼吸困难。
- 结局为随访3至5年的工具性日常生活活动(IADL)和基本日常生活活动(ADL)残疾(现患与 incident),以及最长11年的全因死亡率。
主要发现
- 慢阻肺患者基线衰弱前期(48.8%)和衰弱(6.8%)患病率显著高于非慢阻肺者,衰弱OR为1.61(95%CI 1.15-2.26)。
- 在慢阻肺患者中,衰弱前期或衰弱与现患和 incident IADL及基本ADL残疾以及死亡率的比值约增加两倍相关。
- 与FEV1<80%或呼吸困难联合时,衰弱与现患和 incident IADL及基本ADL残疾的比值增加三至四倍、死亡风险增加二至三倍相关。
- 结合身体衰弱、FEV1<80%和呼吸困难的综合评分在四个风险类别(0、1、2、3-5)中预测现患与 incident IADL及基本ADL残疾和死亡率的梯度更陡,最高风险类别在粗分析中预测风险增加七至8.5倍,协变量调整后仍显著较高。
关键数值与推荐
- 衰弱OR 1.61(95%CI 1.15-2.26)用于比较慢阻肺与非慢阻肺者的衰弱共存风险。
- 慢阻肺患者中衰弱前期或衰弱与IADL及基本ADL残疾和死亡率约两倍风险相关。
- 衰弱联合FEV1<80%或呼吸困难与三至四倍残疾风险和二至三倍死亡风险相关。
- 综合评分最高风险类别(3-5)在粗分析中预测七至8.5倍风险增加。
临床怎么用
- 对慢阻肺患者除肺功能和呼吸困难评估外,应筛查身体衰弱以辅助风险分层。
- 可将身体衰弱、FEV1<80%与呼吸困难联合用于识别残疾和死亡高风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Physical frailty commonly is associated with COPD, and its evaluation in COPD may provide important prognostic information for risk stratification. RESEARCH QUESTIONS: What are the comorbid associations of physical frailty with COPD? Does physical frailty singly and in combination with FEV1 percent predicted and dyspnea predict disability and mortality? STUDY DESIGN AND METHODS: Prospective cohort study of community-dwelling adults 55 years of age or older in the Singapore Longitudinal Ageing Study. Baseline data of 1,162 participants with COPD and 3,465 participants without COPD included physical frailty, FEV1 percent predicted, and dyspnea. Outcome measures were prevalent and incident instrumental activities of daily living (IADL) and basic activities of daily living (ADL) disability at 3 to 5 years of follow-up and all-cause mortality up to 11 years. ORs, hazard ratios, and 95% CIs were adjusted for socioeconomic status, smoking, and comorbidity count. RESULTS: Baseline prevalence of prefrailty (48.8%) and frailty (6.8%) in participants with COPD were significantly higher than in participants without COPD: frailty OR, 1.61; 95% CI, 1.15-2.26. Prefrailty or frailty was associated significantly with twofold increased odds of prevalent and incident IADL and basic ADL disability and mortality in participants with COPD. In combination with FEV1 percent predicted of < 80% or dyspnea, frailty was associated with substantially increased threefold to fourfold odds of prevalent and incident IADL and basic ADL disability, and twofold to threefold increased mortality hazard. A summary score combining physical frailty, FEV1 of < 80%, and dyspnea predicted steeper risk gradients of prevalent and incident IADL and basic ADL disability and mortality across four risk categories (0, 1, 2, 3-5), with the highest risk category predicting between sevenfold and 8.5-fold increased risks in crude analyses, which remained significantly high after covariate adjustment. INTERPRETATION: The study supports the use of physical frailty in addition to lung function and dyspnea in multidimensional evaluation of COPD.
引用
- Lee SY, Nyunt MSZ, Gao Q, et al. Co-occurrence of Physical Frailty and COPD and Association With Disability and Mortality: Singapore Longitudinal Ageing Study. Chest. 2021. PMID: 34914976. doi:10.1016/j.chest.2021.12.633
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。